-
1
-
-
16544375338
-
Diagnoses of HIV/AIDS - 32 states, 2000-2003
-
Centers for Disease Control and Prevention (CDC)
-
Centers for Disease Control and Prevention (CDC). Diagnoses of HIV/AIDS - 32 states, 2000-2003. MMWR Morb Mortal Wkly Rep. 2004;53:1106-1110.
-
(2004)
MMWR Morb Mortal Wkly Rep
, vol.53
, pp. 1106-1110
-
-
-
3
-
-
33744949348
-
2006 Report on the global AIDS epidemic
-
Joint United Nations Programme on HIV/AIDS (UNAIDS). Available at: Accessed: May 13
-
Joint United Nations Programme on HIV/AIDS (UNAIDS). 2006 Report on the global AIDS epidemic. Available at: http://www.unaids.org/en/HIV%5Fdata/ 2006GlobalReport. Accessed: May 13, 2006.
-
(2006)
-
-
-
4
-
-
33748678875
-
-
HIV Infection in Women. National Institute of Allergy and Infectious Diseases Web page. May 2006. Available at: Accessed: May 13
-
HIV Infection in Women. National Institute of Allergy and Infectious Diseases Web page. May 2006. Available at: http://www.niaid.nih.gov/ factsheets/womenhiv.htm. Accessed: May 13, 2006.
-
(2006)
-
-
-
5
-
-
0030863628
-
T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen
-
Quayle AJ, Xu C, Mayer KH, Anderson DJ. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis. 1997;176: 960-968.
-
(1997)
J Infect Dis
, vol.176
, pp. 960-968
-
-
Quayle, A.J.1
Xu, C.2
Mayer, K.H.3
Anderson, D.J.4
-
6
-
-
0032542314
-
Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
-
Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med. 1998;339:1803-1809.
-
(1998)
N Engl J Med
, vol.339
, pp. 1803-1809
-
-
Zhang, H.1
Dornadula, G.2
Beumont, M.3
-
7
-
-
0032739391
-
Prophylactic contraceptives for HIV/AIDS
-
Uckun FM, D'Cruz; OJ. Prophylactic contraceptives for HIV/AIDS. Hum Reprod Update. 1999;5:506-514.
-
(1999)
Hum Reprod Update
, vol.5
, pp. 506-514
-
-
Uckun, F.M.1
D'Cruz, O.J.2
-
8
-
-
0346025452
-
Clinical development of microbicides for the prevention of HIV infection
-
D'Cruz OJ,.Uckun FM. Clinical development of microbicides for the prevention of HIV infection. Curr Pharm Des. 2004;10: 315-336.
-
(2004)
Curr Pharm Des
, vol.10
, pp. 315-336
-
-
D'Cruz, O.J.1
Uckun, F.M.2
-
9
-
-
32644438459
-
Dawn of non-nucleoside inhibitor-based anti-HIV microbicides
-
D'Cruz OJ, Uckun FM. Dawn of non-nucleoside inhibitor-based anti-HIV microbicides. J Antimicrob Chemother. 2006;57:411-423.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 411-423
-
-
D'Cruz, O.J.1
Uckun, F.M.2
-
10
-
-
0031826304
-
Aryl phosphate derivatives of bromo-methoxy-azidothymidine are dual-function spermicides with potent anti-HIV activity
-
D'Cruz OJ, Venkatachalam T, Zhu Z, Shih M, Uckun FM. Aryl phosphate derivatives of bromo-methoxy-azidothymidine are dual-function spermicides with potent anti-HIV activity. Biol Reprod. 1998;59:503-515.
-
(1998)
Biol Reprod
, vol.59
, pp. 503-515
-
-
D'Cruz, O.J.1
Venkatachalam, T.2
Zhu, Z.3
Shih, M.4
Uckun, F.M.5
-
11
-
-
0032935520
-
Synthesis, characterization and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities
-
D'Cruz OJ, Shih M-J, Yiv SH, Chen CL, Uckun FM. Synthesis, characterization and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities. Mol Hum Reprod 1999;5:421-432.
-
(1999)
Mol Hum Reprod
, vol.5
, pp. 421-432
-
-
D'Cruz, O.J.1
Shih, M.-J.2
Yiv, S.H.3
Chen, C.L.4
Uckun, F.M.5
-
12
-
-
0033970759
-
Structural requirements for potent human spermicidal activity of dual-function aryl phosphate derivative of bromo-methoxy zidovudine (WHI-07)
-
D'Cruz OJ, Venkatachalam TK, Uckun FM. Structural requirements for potent human spermicidal activity of dual-function aryl phosphate derivative of bromo-methoxy zidovudine (WHI-07). Biol Reprod. 2000;62:37-44.
-
(2000)
Biol Reprod
, vol.62
, pp. 37-44
-
-
D'Cruz, O.J.1
Venkatachalam, T.K.2
Uckun, F.M.3
-
13
-
-
0037382625
-
Contraceptive activity of a spermicidal aryl phosphate derivative of bromo-methoxy-zidovudine (compound WHI-07) in rabbits
-
D'Cruz OJ, Uckun FM. Contraceptive activity of a spermicidal aryl phosphate derivative of bromo-methoxy-zidovudine (compound WHI-07) in rabbits. Fertil Steril. 2003;79:864-872.
-
(2003)
Fertil Steril
, vol.79
, pp. 864-872
-
-
D'Cruz, O.J.1
Uckun, F.M.2
-
14
-
-
1642420426
-
Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats
-
D'Cruz OJ, Waurzyniak W, Uckun FM. Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats. Antimicrob Agents Chemother. 2004;48: 1082-1088.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 1082-1088
-
-
D'Cruz, O.J.1
Waurzyniak, W.2
Uckun, F.M.3
-
15
-
-
0035172543
-
Thymidine kinase-independent intracellular delivery of bioactive nucleotides by aryl phosphate derivatives of bromo-methoxy zidovudine (WHI-05 and WHI-07) in normal human female genital tract epithelial cells and sperm
-
D'Cruz OJ, Venkatachalam TK, Uckun FM. Thymidine kinase-independent intracellular delivery of bioactive nucleotides by aryl phosphate derivatives of bromo-methoxy zidovudine (WHI-05 and WHI-07) in normal human female genital tract epithelial cells and sperm. Biol Reprod. 2001;64:51-59.
-
(2001)
Biol Reprod
, vol.64
, pp. 51-59
-
-
D'Cruz, O.J.1
Venkatachalam, T.K.2
Uckun, F.M.3
-
16
-
-
0036920022
-
Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and, WHI-07)
-
D'Cruz OJ, Uckun FM. Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and, WHI-07). J Antimicrob Chemother. 2002;50:793-803.
-
(2002)
J Antimicrob Chemother
, vol.50
, pp. 793-803
-
-
D'Cruz, O.J.1
Uckun, F.M.2
-
17
-
-
3042737980
-
Preclinical Overview of WHI-07, a Novel Nucleoside Analog-based Dual-function Microbicide
-
D'Cruz OJ, Uckun FM. Preclinical Overview of WHI-07, a Novel Nucleoside Analog-based Dual-function Microbicide. Curr Med Chem - Anticancer Agents. 2004;3:15-29.
-
(2004)
Curr Med Chem - Anticancer Agents
, vol.3
, pp. 15-29
-
-
D'Cruz, O.J.1
Uckun, F.M.2
-
18
-
-
12944324693
-
Antileukemic activity and cellular metabolism of the aryl phosphate derivative of bromo-methoxy zidovudine (WHI-07)
-
Uckun FM, Tai HL, D'Cruz OJ. Antileukemic activity and cellular metabolism of the aryl phosphate derivative of bromo-methoxy zidovudine (WHI-07). Arzneimittelforschung. 2005;55:50-65.
-
(2005)
Arzneimittelforschung
, vol.55
, pp. 50-65
-
-
Uckun, F.M.1
Tai, H.L.2
D'Cruz, O.J.3
-
19
-
-
0024354972
-
Microemulsions as topical delivery vehicles: Ocular administration of timolol
-
Gasco MR, Gallarate M, Trotta M, Bauchiero L, Gremmo E, Chiappero O. Microemulsions as topical delivery vehicles: ocular administration of timolol. J Pharm Biomed Anal. 1989;7:433-439.
-
(1989)
J Pharm Biomed Anal
, vol.7
, pp. 433-439
-
-
Gasco, M.R.1
Gallarate, M.2
Trotta, M.3
Bauchiero, L.4
Gremmo, E.5
Chiappero, O.6
-
20
-
-
0025798935
-
Microemulsions as topical drug delivery vehicles: In-vitro transdermal studies of a model hydrophilic drug
-
Osborne DW, Ward AJ, O'Neill KJ. Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol. 1991;43:450-454.
-
(1991)
J Pharm Pharmacol
, vol.43
, pp. 450-454
-
-
Osborne, D.W.1
Ward, A.J.2
O'Neill, K.J.3
-
21
-
-
0034614208
-
Microemulsion-based media as novel drug delivery systems
-
Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89-121.
-
(2000)
Adv Drug Deliv Rev
, vol.45
, pp. 89-121
-
-
Lawrence, M.J.1
Rees, G.D.2
-
22
-
-
0033861445
-
Evaluation of subchronic (13-week) and reproductive toxicity potential of intravaginal gel-microemulsion formulation of a dual-function phenyl phosphate derivative of bromo-methoxy zidovudine (WHI-07) in B6C3F1 mice
-
D'Cruz OJ, Waurzyniak B, Yiv SH, Uckun FM. Evaluation of subchronic (13-week) and reproductive toxicity potential of intravaginal gel-microemulsion formulation of a dual-function phenyl phosphate derivative of bromo-methoxy zidovudine (WHI-07) in B6C3F1 mice. J Appl Toxicol. 2000;20:319-325.
-
(2000)
J Appl Toxicol
, vol.20
, pp. 319-325
-
-
D'Cruz, O.J.1
Waurzyniak, B.2
Yiv, S.H.3
Uckun, F.M.4
-
23
-
-
0034885693
-
Lack of adverse effects on fertility of female CD-1 mice exposed to repetitive intravaginal gel-microemulsion formulation of a dual-function anti-HIV agent: Aryl phosphate derivative of bromo-methoxy-zidovudine (compound WHI-07)
-
D'Cruz OJ, Uckun FM. Lack of adverse effects on fertility of female CD-1 mice exposed to repetitive intravaginal gel-microemulsion formulation of a dual-function anti-HIV agent: aryl phosphate derivative of bromo-methoxy-zidovudine (compound WHI-07). J Appl Toxicol. 2001;21:317-322.
-
(2001)
J Appl Toxicol
, vol.21
, pp. 317-322
-
-
D'Cruz, O.J.1
Uckun, F.M.2
-
24
-
-
0035073006
-
Short-term (13-week) toxicity study of 5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent, in B6C3F1 mice
-
D'Cruz OJ, Uckun FM. Short-term (13-week) toxicity study of 5-bromo-6-methoxy-5,6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent, in B6C3F1 mice. Toxicol Sci. 2001;60:373-378.
-
(2001)
Toxicol Sci
, vol.60
, pp. 373-378
-
-
D'Cruz, O.J.1
Uckun, F.M.2
-
25
-
-
0034766237
-
Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles
-
D'Cruz OJ, Uckun FM. Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles. Contraception. 2001;64: 113-123.
-
(2001)
Contraception
, vol.64
, pp. 113-123
-
-
D'Cruz, O.J.1
Uckun, F.M.2
-
26
-
-
0037200764
-
Two-year toxicity and carcinogenicity studies in B6C3F1 mice with 5-bromo-6-methoxy-5, 6-dihydro-3′-azidothymidine-5′-(p-bromophenyl) methoxy alaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent
-
D'Cruz OJ, Erbeck D, Waurzyniak W, Uckun FM. Two-year toxicity and carcinogenicity studies in B6C3F1 mice with 5-bromo-6-methoxy-5, 6-dihydro-3'-azidothymidine-5'-(p-bromophenyl) methoxy alaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent. Toxicology, 2002;179:61-67.
-
(2002)
Toxicology
, vol.179
, pp. 61-67
-
-
D'Cruz, O.J.1
Erbeck, D.2
Waurzyniak, W.3
Uckun, F.M.4
-
27
-
-
0242552309
-
Developmental toxicology studies of WHI-07, a novel nucleoside analogue-based dual-function microbicide, administered intravaginally to rabbits
-
D'Cruz OJ, Erbeck D, Uckun FM. Developmental toxicology studies of WHI-07, a novel nucleoside analogue-based dual-function microbicide, administered intravaginally to rabbits. Toxicol Pathol. 2003;31:698-708.
-
(2003)
Toxicol Pathol
, vol.31
, pp. 698-708
-
-
D'Cruz, O.J.1
Erbeck, D.2
Uckun, F.M.3
-
28
-
-
22244484135
-
A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate
-
D'Cruz OJ, Erbeck D, Uckun FM. A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate. Toxicol Pathol. 2005;33:465-476.
-
(2005)
Toxicol Pathol
, vol.33
, pp. 465-476
-
-
D'Cruz, O.J.1
Erbeck, D.2
Uckun, F.M.3
-
29
-
-
0000009718
-
Microemulsion
-
In: Swarbrick J, Boylan JC, eds. New York, NY Marcel Dekker
-
Eccleston GM. Microemulsion. In: Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. New York, NY Marcel Dekker, 1992:375-421.
-
(1992)
Encyclopedia of Pharmaceutical Technology
, pp. 375-421
-
-
Eccleston, G.M.1
-
30
-
-
0033430984
-
Microemulsions: An overview and pharmaceutical applications
-
Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst. 1999;16:461-521.
-
(1999)
Crit Rev Ther Drug Carrier Syst
, vol.16
, pp. 461-521
-
-
Tenjarla, S.1
|